Press Release: Nano Dimension Announces Financial Results for the First Quarter 2026

Dow Jones05-08

Recent Strategic Actions Expected to Reduce Annualized Cash Burn by Approximately $10 million

Company Executing Three Phase Plan to Maximize Shareholder Value in 2026 and Beyond

Full Year 2026 Guidance Suspended as Strategic Alternatives Process Accelerates

WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) ("Nano Dimension", "Nano", or the "Company"), a leader in digital manufacturing solutions, today announced financial results for the first quarter ended March 31, 2026.

First Quarter 2026 Results:

   -- Revenue: $29.7 million, a 106% increase from $14.4 million year-over-year 
 
   -- Gross Margin ("GM"): 40.8%, up from 40.6% year-over-year 
 
   -- Adjusted Gross Margin ("Adjusted GM"): 45.9%, up from 43.3% 
      year-over-year 
 
   -- Adjusted EBITDA loss: $12.5 million, up from a loss of $10.1 million 
      year-over-year 
 
   -- Net Loss: $69.7 million, inclusive of $40.4 million of impairment, up 
      from a loss of $25.5 million year-over-year 
 
   -- Total cash, cash equivalents, deposits, restricted deposits and 
      marketable equity securities: $441.6 million as of March 31, 2026, down 
      from $459.6 million as of December 31, 2025. 

Adjusted EBITDA and Adjusted Gross Margin are non-GAAP financial measures. More information, including a reconciliation of Adjusted EBITDA and Adjusted Gross Margin to the most directly comparable GAAP financial measure can be found below in this press release under "Non-GAAP Financial Measures" and "Reconciliation of US GAAP to Non-GAAP Measures."

Recent Developments:

Three Phase Strategic Plan Execution: The Company is executing a defined three phase plan to maximize shareholder value in 2026 and beyond, with each phase already underway. Phase One is focused on streamlining operations and reducing cash burn through efficiency initiatives and disciplined cost management. Phase Two is centered on monetization of product lines to simplify the business and strengthen the balance sheet, including the announced sale of its additively manufactured electronics ("AME") and Fabrica product lines. Phase Three is focused on evaluating strategic alternatives to maximize long term shareholder value and selecting the most compelling path forward, which remains under review.

David Stehlin, Chief Executive Officer, commented, "The three phases of our strategic plan continue to advance in parallel as we accelerate toward increasing shareholder value. We are streamlining operations, monetizing our product lines, and progressing toward potentially selecting a compelling opportunity in the coming months. We have completed the sale of our AME and Fabrica product lines and expect to announce additional product line monetization in the coming weeks. Together, these actions are expected to reduce complexity, lower annualized cash burn, and further strengthen our financial flexibility. Phase 3 is advancing quickly. After receiving numerous inbound opportunities, we have significantly narrowed our focus and are now reviewing a short list of highly attractive strategic alternatives, which we believe have the potential to deliver significant long term value creation in 2026 and beyond."

Sale of AME and Fabrica Product Lines: On April 6, 2026, Nano Dimension announced the sale of its AME product line and its previously discontinued Fabrica product lines to Inspira Technologies OXY B.H.N. Ltd. for total consideration of up to $12.5 million, including a $2.0 million upfront cash payment and up to $10.5 million in performance-based deferred payments over the next twelve months. This transaction supports the Company's efforts to streamline operations and lower its cost structure. The Company expects this transaction to reduce annualized cash burn by approximately $10 million.

2026 Financial Guidance Update

Given the Company's ongoing actions under its defined strategic plan and the potential for additional changes across the business, the Company has suspended its full year 2026 financial guidance at this time.

This decision reflects the range of outcomes currently being implemented and evaluated, including the timing and scope of potential monetization actions that could materially impact future results.

Conference Call Today

Nano Dimension will host a conference call today at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2026.

Participants can pre-register for the conference call in order to receive dial in information via this link: https://dpregister.com/sreg/10208731/103e987e1a7

Participants can also dial-in/connect by following the below:

Listen in via U.S. dial-in: 1-844-695-5517

Listen via international dial-in: 1-412-902-6751

Listen via Israel toll free: 1-80-9212373

Listen via webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=ZaodVpNh

For those unable to participate in the conference call, there will be a replay available from a link on Nano Dimension's website at https://investors.nano-di.com/events-and-presentations.

About Nano Dimension Ltd.

Driven by strong trends in onshoring, national security, and increasing product customization, Nano Dimension Ltd. (Nasdaq: NNDM) delivers advanced Digital Manufacturing technologies to the defense, aerospace, automotive, electronics, and medical devices industries, enabling rapid deployment of high-mix, low-volume production with IP security and sustainable manufacturing practices. For more information, please visit https://www.nano-di.com/.

Non-GAAP Financial Measures

EBITDA is a non-GAAP measure and is defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization. We believe that EBITDA should be useful in evaluating the performance of our business and operations. EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting interest expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively) and EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company's operating performance without regard to the items mentioned above.

Adjusted EBITDA and operating expenses are non-GAAP measures and are defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization, share-based compensation expense, exchange rate differences, finance expenses (income) for revaluation of assets and liabilities, Desktop Metal litigation related expenses, Desktop Metal and Markforged transaction related expenses, restructuring costs, impact of deconsolidation, impairment losses, litigation settlements and step-up amortization from purchase accounting. We believe that Adjusted EBITDA and operating expenses, as described above, should also be useful in evaluating the performance of our business. Like EBITDA, Adjusted EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting other financial expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from share-based payments, restructuring costs, impairment losses, and step-up amortization from purchase accounting. Adjusted EBITDA and operating expenses are useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company's operating performance without regard to non-cash items, such as expenses related to share-based payments.

Adjusted gross profit, excluding depreciation and amortization, share-based compensation expenses, and step-up amortization from purchase accounting, is a non-GAAP measure. We believe that adjusted gross profit, as described above, should also be useful in evaluating the performance of our business. Adjusted gross profit facilitates gross profit and gross margin comparisons from period to period and company to company by backing out potential differences caused by variations in amortization of inventory and intangible assets. Adjusted gross profit is useful to an investor in evaluating our performance because it enables investors, securities analysts and other interested parties to measure a company's performance without regard to non-cash items, such as amortization expenses. Adjusted gross margin is calculated by dividing the adjusted gross profit by the revenues.

EBITDA and Adjusted EBITDA, Adjusted gross profit and non-GAAP operating expenses can be useful in evaluating our performance by eliminating the effect of financing and non-cash expenses such as share-based payments, however, we may incur such expenses in the future, which could impact future results. In addition, other companies, including companies in our industry, may calculate non-GAAP metrics differently or not at all, which may reduce the usefulness of this measure as a tool for comparison.

Nano Dimension does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures due to the inherent difficulty in forecasting and quantifying certain significant items. These items are uncertain, depend on various factors and could have a material impact on GAAP reported results for the relevant period.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements regarding Nano's future growth, strategic plan and value to shareholders; the Company's expectation that the phases of the strategic plan will increase shareholder value, streamline operations, monetize product lines and progress toward potentially selecting a compelling opportunity; the Company's expectations that it will announce additional product line monetization in the coming weeks; the Company's expectations in the success of future strategic alternatives in reducing complexity, lowering annualized cash burn, strengthening the Company's financial flexibility and delivering significant long term value creation in 2026 and beyond; and all other statements other than statements of historical fact that address activities, events or developments that Nano intends, expects, projects, believes or anticipates will or may occur in the future. Forward-looking statements may be characterized by terminology such as "believe," "project," "expect," "anticipate," "estimate," "forecast," "outlook," "target," "endeavor," "seek," "predict," "intend," "strategy," "plan," "may," "could," "should," "will," "would," "will be," "will continue," "will likely result," or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. Such statements are based on management's beliefs and assumptions made based on information currently available to management. These forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results and performance to be materially different from those expressed or implied in the forward-looking statements. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, estimates and uncertainties that are difficult to predict. Because such statements deal with future events and are based on the current expectations of Nano, they are subject to various risks and uncertainties. The forward-looking statements contained or implied in this communication are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Nano's annual report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 31, 2026, and in any subsequent filings with the SEC. Except as otherwise required by law, Nano undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this communication.

Contacts:

Investors: Purva Sanariya

Director, Investor Relations

ir@nano-di.com

Media: Samuel Manning

Principal Manager, External Communications

press@nano-di.com

 
                         NANO DIMENSION LTD. 
                 CONDENSED CONSOLIDATED BALANCE SHEETS 
      (In thousands, except share and per share data) (Unaudited) 
                                        March 31,     December 31, 
                                       -----------   -------------- 
                                          2026            2025 
                                       -----------   -------------- 
Assets 
Current assets: 
Cash and cash equivalents              $   355,278    $     204,672 
Bank deposits                                8,781          168,997 
Marketable equity securities                75,719           84,154 
Restricted bank deposits                       594              123 
Trade receivables, net of allowance 
 for doubtful accounts ($939 and 
 $861, respectively)                        22,700           26,047 
Inventory                                   31,703           32,878 
Other current assets                        10,622            8,938 
                                        ----------       ---------- 
Total current assets                       505,397          525,809 
Restricted bank deposits                     1,254            1,610 
Property, plant and equipment, net          23,621           24,840 
Operating lease right-of-use assets         22,487           23,789 
Deferred tax assets                            424              424 
Goodwill                                        --           40,388 
Intangible assets, net                      18,313           19,434 
Other assets                                 1,711            1,930 
                                        ----------       ---------- 
Total assets                           $   573,207    $     638,224 
                                        ==========       ========== 
Liabilities and Equity 
Current liabilities: 
Trade payables                         $    12,974    $      11,999 
Accrued liabilities                         21,083           19,514 
Deferred revenue                            13,250           11,873 
Current portion of lease liability           8,604            8,923 
Current portion of bank loan                   156              158 
                                        ----------       ---------- 
Total current liabilities                   56,067           52,467 
Employee benefits                            3,666            3,697 
Operating lease right-of-use 
 liabilities                                21,563           23,323 
Bank loan                                      117              158 
Long-term settlement payable                 3,124            2,974 
Long-term deferred revenue                   3,226            3,617 
                                        ----------       ---------- 
Total liabilities                           87,763           86,236 
Commitments and contingencies 
Equity: 
Share capital of NIS 5 par value 
 each; 500,000,000 ordinary shares 
 authorized; 207,986,287 and 
 206,811,875 shares outstanding as of 
 March 31, 2026 and December 31, 
 2025, respectively, and 280,480,934 
 and 279,306,522 shares issued as of 
 March 31, 2026 and December 31, 
 2025, respectively.                       418,969          417,084 
Additional paid-in capital               1,298,363        1,297,323 
Treasury stock                            (192,507)        (192,507) 
Accumulated other comprehensive 
 income                                      1,241            1,048 
Accumulated loss                        (1,040,622)        (970,960) 
                                        ----------       ---------- 
Total equity                               485,444          551,988 
                                        ----------       ---------- 
Total liabilities and equity           $   573,207    $     638,224 
                                        ==========       ========== 
 
 
                          NANO DIMENSION LTD. 
             CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
            (In thousands, except per share data) (Unaudited) 
                                      Three months ended March 31, 
                                   ---------------------------------- 
                                       2026(1)               2025 
                                   ----------------      ------------ 
Revenue: 
Product                             $        22,931      $     11,679 
Service                                       6,794             2,722 
                                       ------------       ----------- 
Total revenue                                29,725            14,401 
Cost of revenue: 
Product                                      14,222             7,081 
Service                                       3,376             1,479 
                                       ------------       ----------- 
Total cost of revenue                        17,598             8,560 
                                       ------------       ----------- 
Gross profit                                 12,127             5,841 
Operating expenses: 
Research and development                      8,204             5,944 
Sales and marketing                           9,692             5,644 
General and administrative                   15,209             5,667 
Restructuring                                 3,127             1,180 
Desktop Metal litigation                         --            28,069 
Impairment losses                            40,388             1,229 
                                       ------------       ----------- 
Operating loss                              (64,493)          (41,892) 
(Loss) gain on investment in 
 marketable equity securities                (8,435)            8,726 
Finance income                                3,512             9,320 
Finance expense                                (246)           (1,679) 
                                       ------------       ----------- 
Loss before income taxes                    (69,662)          (25,525) 
Income tax expense                               --               (23) 
                                       ------------       ----------- 
Net loss                                    (69,662)          (25,548) 
                                       ------------       ----------- 
Less: Net loss attributable to 
 non-controlling interests                       --              (236) 
                                       ------------       ----------- 
Net loss attributable to common 
 shareholders                       $       (69,662)     $    (25,312) 
                                       ============       =========== 
 
Net loss attributable to common 
shareholders: 
Basic and diluted                   $         (0.34)     $      (0.12) 
 
Weighted average common shares 
 outstanding, basic and diluted             207,504           216,462 
Net loss                            $       (69,662)     $    (25,548) 
Other comprehensive income: 
Foreign currency translation 
 adjustment                                     193               593 
                                       ------------       ----------- 
Comprehensive loss                          (69,469)          (24,955) 
Less: Comprehensive loss 
 attributable to non-controlling 
 interests                                       --              (224) 
                                       ------------       ----------- 
Comprehensive loss attributable 
 to common shareholders             $       (69,469)     $    (24,731) 
                                       ============       =========== 
 
 (1) The results for the three months ended March 31, 
 2026 include the consolidation of Markforged revenue 
 of $17.1 million, gross profit of $6.0 million, and 
 GAAP net loss of $50.1 million. 
 
 
                           NANO DIMENSION LTD. 
              CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 
                        (In thousands) (Unaudited) 
                               For the Three Months Ended March 31, 
                           -------------------------------------------- 
                                   2026                     2025 
                           --------------------      ------------------ 
Cash flow from operating 
activities 
Net loss                     $          (69,662)      $         (25,548) 
Adjustments: 
Depreciation, 
 amortization and 
 non-cash lease interest                  3,701                     574 
Impairment losses                        40,388                   1,229 
Changes in fair value of 
 equity securities                        8,435                  (8,726) 
Share-based compensation 
 expense                                  2,925                    (786) 
Changes in assets and 
liabilities: 
(Increase) decrease in 
 inventory                                  425                     340 
(Increase) in other 
 current assets                          (1,500)                   (371) 
Decrease (increase) in 
 trade receivables                        3,258                  (2,881) 
Increase (decrease)in 
 other payables                           1,609                  (4,026) 
(Decrease) increase in 
 employee benefits                          (20)                     38 
Increase in trade 
 payables                                 1,019                  26,362 
Other                                     2,343                   6,316 
                           ---  ---------------          -------------- 
Net cash used in 
 operating activities                    (7,079)                 (7,479) 
                           ---  ---------------          -------------- 
Cash flow relating to 
investing activities 
Change in bank deposits                 157,651                 177,395 
Purchase of property 
 plant and equipment                       (167)                   (295) 
Net cash from investing 
 activities                             157,484                 177,100 
                           ---  ---------------          -------------- 
Cash flow relating to 
financing activities 
Repayment long-term bank 
 debt                                       (41)                    (35) 
Net cash used in 
 financing activities                       (41)                    (35) 
                           ---  ---------------          -------------- 
Increase in cash, cash 
 equivalents and 
 restricted cash                        150,364                 169,586 
Effect of exchange rate 
 fluctuations on cash                       357                     204 
Cash, cash equivalents 
 and restricted cash at 
 beginning of the period                206,405                 318,474 
                           ---  ---------------          -------------- 
Cash, cash equivalents 
 and restricted cash at 
 end of the period           $          357,126       $         488,264 
                           ===  ===============          ============== 
 
Supplemental disclosures 
of cash flow 
information 
Cash and cash equivalents    $          355,278                 487,438 
Restricted cash in 
 restricted deposits, 
 current                                    594                      60 
Restricted cash in 
 restricted deposits, 
 non-current                              1,254                     766 
                           ---  ---------------          -------------- 
Total cash, cash 
 equivalents and 
 restricted cash shown in 
 the condensed 
 consolidated statements 
 of cash flows               $          357,126       $         488,264 
                           ===  ===============          ============== 
 
Non-cash operating and 
investing activity 
Lease liabilities arising 
 from obtaining 
 right-of-use assets                         --                     119 
Supplemental disclosure 
of cash flow 
information 
Income taxes paid during 
 the year                                    --                      60 
 
 
                         NANO DIMENSION LTD. 
            RECONCILIATION OF US GAAP TO NON-GAAP MEASURES 
                      (In thousands) (Unaudited) 
                                               Three Months Ended 
                                                    March 31, 
                                             ---------------------- 
                                                2026         2025 
                                             -----------   -------- 
GAAP Net loss                                 $  (69,662)  $(25,548) 
Tax expense                                           --         23 
Depreciation and amortization                      2,432        574 
Interest expense                                     221         -- 
Interest income                                   (3,652)    (9,309) 
                                                 -------    ------- 
Non-GAAP EBITDA (loss)                           (70,661)   (34,260) 
Finance expenses (income) from revaluation 
 of assets and liabilities                         8,434     (8,726) 
Exchange rate differences                            140      1,639 
Share-based payments expense                       2,925       (786) 
Desktop Metal litigation related expenses             --     28,069 
Desktop Metal and Markforged transaction 
 related expenses                                    556      1,515 
Restructuring costs                                3,127      1,180 
Impairment losses                                 40,388      1,229 
Acquisition inventory step-up amortization           616         -- 
Litigation, settlements, and contingencies         1,951         -- 
                                                 -------    ------- 
Non-GAAP Adjusted EBITDA                      $  (12,524)  $(10,140) 
                                                 =======    ======= 
 
 
                                               Three Months Ended 
                                                    March 31, 
                                             ---------------------- 
Non-GAAP Cost of Revenue                        2026         2025 
                                             -----------   -------- 
GAAP Cost of revenue                          $   17,598   $  8,560 
Share-based payments expense                         158        246 
Depreciation and amortization                        739        142 
Acquisition inventory step-up amortization           616         -- 
                                                 -------    ------- 
Non-GAAP Cost of revenue                      $   16,085   $  8,172 
                                                 =======    ======= 
 
 
                                               Three Months Ended 
                                                    March 31, 
                                             ---------------------- 
Non-GAAP Gross Profit                           2026         2025 
                                             -----------   -------- 
GAAP Gross profit                             $   12,127   $  5,841 
Share-based payments expense                         158        246 
Depreciation and amortization                        739        142 
Acquisition inventory step-up amortization           616         -- 
                                                 -------    ------- 
Non-GAAP Gross profit                         $   13,640   $  6,229 
                                                 =======    ======= 
 
 
                                               Three Months Ended 
                                                    March 31, 
                                             ---------------------- 
Non-GAAP Research and Development Expenses      2026         2025 
                                             -----------   -------- 
GAAP Research and development expenses        $    8,204   $  5,944 
Share-based payments expense                         478         69 
Depreciation and amortization                        404        209 
                                                 -------    ------- 
Non-GAAP Research and development expenses    $    7,322   $  5,666 
                                                 =======    ======= 
 
 
                                               Three Months Ended 
                                                    March 31, 
                                             ---------------------- 
Non-GAAP Sales and Marketing Expenses           2026         2025 
                                             -----------   -------- 
GAAP Sales and marketing expenses             $    9,692   $  5,644 
Share-based payments expense                         200        323 
Depreciation and amortization                        904         43 
                                                 -------    ------- 
Non-GAAP Sales and marketing expenses         $    8,588   $  5,278 
                                                 =======    ======= 
 
 

(MORE TO FOLLOW) Dow Jones Newswires

May 07, 2026 16:05 ET (20:05 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment